Search

...Tecentriq® (atezolizumab) is a drug that may be used for the treatment of certain forms of lung cancer in adults. Tecentriq may be used alone as a first treatment in...

...Opdivo (nivolumab) is an immunotherapy that is used to treat certain cases of non-small cell lung cancer (NSCLC) in adults. Opdivo may be used: Your doctor will perform a genetic...

...Tagrisso (osimertinb) is a targeted therapy that is used to treat adults with non-small cell lung cancer (NSCLC) that has epidermal growth factor receptor (EGFR) genes with exon 19 deletions...

...Pulmonary rehabilitation is the name given to various services that aim to improve the lung functioning of people with chronic lung disease. Pulmonary rehabilitation is used to help people with...

...Radiofrequency ablation (RFA) is the use of high-energy electrical waves to heat and destroy cancerous (malignant) cells. The electrical currents are delivered by the use of a needle electrode that...

...Keytruda (pembrolizumab) is an immunotherapy that is used to treat certain cases of non-small cell lung cancer (NSCLC) in adults. Keytruda may be used: Your doctor will perform a genetic...

...Immunotherapy is a type of drug used to treat cancer. Several immunotherapies are approved to treat lung cancer. They boost your body’s immune system to fight cancer cells. You may...

...Cyramza (ramucirumab) is a targeted therapy that is used to treat some adults with non-small cell lung cancers (NSCLC). Cyramza may be used: Your doctor will perform a genetic test...

...Avastin (bevacizumab) is a targeted therapy that is approved to treat some adults with advanced non-squamous non-small cell lung cancers (NSCLC). Avastin is used as a first-line treatment along with the...

...Zykadia (ceritinib) is a targeted therapy that is used to treat adults with non-small cell lung cancers (NSCLC) that: About 5 percent of all lung cancers are ALK-positive. People who...

...Xalkori (crizotinib) is a targeted therapy that is used to treat adults with non-small cell lung cancers (NSCLC) that: About 5 percent of all lung cancers are ALK-positive. People who develop...

...Alecensa (alectinib) is a targeted therapy that is used to treat adults with non-small cell lung cancers (NSCLC) that: About 5 percent of all lung cancers are ALK-positive. People who develop...

...Tarceva is a targeted therapy that is used to treat some non-small cell lung cancers (NSCLC) that have a certain EGFR (epidermal growth factor receptor) mutation, specifically the exon 19...

...Portrazza (necitumumab) is approved by the US Food and Drug Administration (FDA) as an initial treatment for metastatic squamous non-small cell lung cancer (NSCLC). Metastatic means the cancer has spread...

...Iressa (gefitinib) is a targeted therapy that is used to treat people with non-small cell lung cancer (NSCLC) that has: Your doctor will perform a genetic test to find out...

...Gilotrif (afatinib) is a prescription drug used to treat people with non-small cell lung cancers (NSCLC) that has: Gilotrif is a targeted therapy for EGFR genes. Your doctor will perform...

...Many lung cancer treatments that kill cancer cells also affect healthy cells. This can cause side effects. But some lung cancer drugs specifically target cancer cells, so they help reduce...

...Topoisomerase inhibitors are a type of chemotherapy used to treat certain forms of lung cancer. They work by blocking enzymes that allow DNA to be copied. This prevents cell division...

...Mitotic inhibitors are a type of chemotherapy used to treat many cancers. Often, they are used to treat non-small cell lung cancer (NSCLC). They work by blocking the process of...

...Antimetabolites are a type of chemotherapy used to treat many cancers. Some antimetabolite drugs are used to treat certain forms of lung cancer. These drugs look like chemicals that cells...